Eagle Veterinary Technology Co.,Ltd (KOSDAQ:044960)
3,035.00
-60.00 (-1.94%)
At close: Jun 19, 2026
KOSDAQ:044960 Revenue
Eagle Veterinary Technology Co.,Ltd had revenue of 11.01B KRW in the quarter ending March 31, 2026, with 2.68% growth. This brings the company's revenue in the last twelve months to 43.61B, up 4.19% year-over-year. In the year 2025, Eagle Veterinary Technology Co.,Ltd had annual revenue of 43.32B with 3.85% growth.
Revenue (ttm)
43.61B
Revenue Growth
+4.19%
P/S Ratio
0.88
Revenue / Employee
670.92M
Employees
65
Market Cap
38.37B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 43.32B | 1.61B | 3.85% |
| Dec 31, 2024 | 41.72B | -1.08B | -2.52% |
| Dec 31, 2023 | 42.79B | -746.00M | -1.71% |
| Dec 31, 2022 | 43.54B | 3.10B | 7.67% |
| Dec 31, 2021 | 40.44B | 80.27M | 0.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Korea Arlico Pharm | 199.14B |
| RP Bio | 137.35B |
| Jin Yang Pharmaceutical | 122.15B |
| GeneBioTech Co. ,Ltd | 89.44B |
| Sinil Pharmaceutical | 82.18B |
| Korean Drug | 62.76B |
| Kyung Nam Pharm | 56.18B |
| HLscience | 13.76B |